Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Leukemia
|
July 18, 2024
Retraction Note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex
M Konopleva, M Milella, P Ruvolo, et al.
Leukemia
|
March 26, 2011
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway
A M Martelli, C Evangelisti, W Chappell, et al.
Leukemia
|
October 9, 2021
RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences
Anneke D van Dijk, Ti'ara L Griffen, Yihua H Qiu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
April 16, 2018
Role of MSC-derived galectin 3 in the AML microenvironment
Peter P Ruvolo, Vivian R Ruvolo, Jared K Burks, et al.
Leukemia
|
April 16, 2011
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
L S Steelman, R A Franklin, S L Abrams, et al.
Biochimica Et Biophysica Acta
|
May 27, 2014
The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells
Peter P Ruvolo, Vivian R Ruvolo, Rodrigo Jacamo, et al.
Annals of Hematology
|
May 6, 2004
Targeted therapy of AML new concepts
M Andreeff, M Milella, B Z Carter, et al.
Haematologica
|
March 17, 2018
Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival
Steven M Kornblau, Peter P Ruvolo, Rui-Yu Wang, et al.
Haematologica
|
November 4, 2021
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill <i>FLT3</i>-ITD acute myeloid leukemia
Sean M Post, Huaxian Ma, Prerna Malaney, et al.
Blood
|
September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report
Fieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Leukemia
|
July 18, 2024
Retraction Note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex
M Konopleva, M Milella, P Ruvolo, et al.
Leukemia
|
March 26, 2011
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway
A M Martelli, C Evangelisti, W Chappell, et al.
Leukemia
|
October 9, 2021
RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences
Anneke D van Dijk, Ti'ara L Griffen, Yihua H Qiu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
April 16, 2018
Role of MSC-derived galectin 3 in the AML microenvironment
Peter P Ruvolo, Vivian R Ruvolo, Jared K Burks, et al.
Leukemia
|
April 16, 2011
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
L S Steelman, R A Franklin, S L Abrams, et al.
Biochimica Et Biophysica Acta
|
May 27, 2014
The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells
Peter P Ruvolo, Vivian R Ruvolo, Rodrigo Jacamo, et al.
Annals of Hematology
|
May 6, 2004
Targeted therapy of AML new concepts
M Andreeff, M Milella, B Z Carter, et al.
Haematologica
|
March 17, 2018
Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival
Steven M Kornblau, Peter P Ruvolo, Rui-Yu Wang, et al.
Haematologica
|
November 4, 2021
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill <i>FLT3</i>-ITD acute myeloid leukemia
Sean M Post, Huaxian Ma, Prerna Malaney, et al.
Blood
|
September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report
Fieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Page
of 9